Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Reply to comment on: “Advantag...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity”

Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity”

Bibliographic Details
Main Authors: Sidney A Schechet, Sarah Hilkert Rodriguez, Michael J Shapiro, Michael P Blair
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Taiwan Journal of Ophthalmology
Online Access:http://www.e-tjo.org/article.asp?issn=2211-5056;year=2019;volume=9;issue=2;spage=136;epage=137;aulast=Schechet
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.e-tjo.org/article.asp?issn=2211-5056;year=2019;volume=9;issue=2;spage=136;epage=137;aulast=Schechet

Similar Items

  • Bevacizumab or laser for aggressive posterior retinopathy of prematurity
    by: Michael Blair, et al.
    Published: (2018-01-01)
  • Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity”
    by: Ramanuj Samanta
    Published: (2019-01-01)
  • Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity
    by: Azad Rajvardhan, et al.
    Published: (2007-01-01)
  • Favorable outcomes of adequate laser photocoagulation and salvage bevacizumab treatment for aggressive posterior retinopathy of prematurity
    by: Yoko Fukushima, et al.
    Published: (2018-09-01)
  • Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity
    by: Murat Gunay, et al.
    Published: (2015-10-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...
Cannot write session to /tmp/vufind_sessions/sess_4edf2qduten8rm5q2h172uc8j1